Literature DB >> 7951256

(ATT) trinucleotide repeats in the antithrombin gene and their use in determining the origin of repeated mutations.

R J Olds1, D A Lane, V Chowdhury, G Sas, I Pabinger, K Auberger, S L Thein.   

Abstract

Two (ATT) trinucleotide repeat polymorphisms have been identified in the tails of Alu repeat elements in intron 5 of the antithrombin gene. The frequency and distribution of allele sizes for the Alu 5 and Alu 8 tail polymorphisms have been defined in a sample Caucasian population. The Alu 5 polymorphism has two alleles while that of Alu 8 has 10 alleles with a heterozygosity of 0.83. These polymorphisms have been used in combination with four previously described polymorphisms within the antithrombin gene to construct antithrombin gene haplotypes in the sample Caucasian population. Twenty-two different haplotypes were observed, with the Alu 8 polymorphism being particularly useful in subdividing the core haplotype based on the previously identified polymorphisms. The haplotype data were used to investigate the origin of repeat mutations within the antithrombin locus. We compared the haplotypes associated the mutant antithrombin genes in five families with the mutation 2759C-->T (L99F) and five families with the mutation 5381C-->T (R129Stop). The mutation 2759C-->T (L99F), which occurs within a non-CpG dinucleotide, was carried on a gene associated with an identical haplotype in each of the five families. The mutation 5381C-->T (R129Stop), a single base substitution within a CpG dinucleotide, was associated with at least two different haplotypes. The findings suggest a founder effect in the five families sharing the 2759C-->T (L99F) and at least two independent origins for the CpG dinucleotide mutation 5381C-->T (R129Stop).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7951256     DOI: 10.1002/humu.1380040105

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  3 in total

Review 1.  Inherited thrombophilia: memorandum from a joint WHO/International Society on Thrombosis and Haemostasis meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

2.  Three novel missense mutations in the antithrombin III (AT3) gene causing recurrent venous thrombosis.

Authors:  D S Millar; A I Wacey; J Ribando; E Melissari; B Laursen; P Woods; V V Kakkar; D N Cooper
Journal:  Hum Genet       Date:  1994-11       Impact factor: 4.132

3.  Deficiencies of the Natural Anticoagulants - Novel Clinical Laboratory Aspects of Thrombophilia Testing.

Authors:  Zsuzsanna Bereczky; Réka Gindele; Marianna Speker; Judit Kállai
Journal:  EJIFCC       Date:  2016-04-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.